Infliximab for the treatment of rheumatoid arthritis
Cochrane database of systematic reviews, July 2002
Barbara BTB Blumenauer, Maria Judd, George A Wells, Amanda Burls, Ann Cranney, Marc C Hochberg, Peter Tugwell, Maria Angeles Lopez-Olivo
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||15||14%|
|Student > Bachelor||13||12%|
|Student > Ph. D. Student||11||10%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||36||34%|
|Nursing and Health Professions||8||7%|
|Pharmacology, Toxicology and Pharmaceutical Science||5||5%|
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2021.
All research outputs
of 23,150,406 outputs
Outputs from Cochrane database of systematic reviews
of 12,383 outputs
Outputs of similar age
of 44,572 outputs
Outputs of similar age from Cochrane database of systematic reviews
of 34 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,383 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.5. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 44,572 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.